Lorillard Suit Alleges Financial Conflict and Bias Among Fda Advisory Committee Members

Summary


GREENSBORO, N.C., Feb. 25, 2011 /PRNewswire/ -- Highlighting conflicts of interest and bias among members of a Food and Drug Administration (FDA) scientific advisory committee, Lorillard, Inc. (NYSE: LO) today filed suit to stop FDA from receiving or relying on recommendations from the advisory committee, including recommendations regarding the use of menthol in cigarettes. In the complaint, Lorillard also asks the Court to enjoin the FDA from making available to the advisory committee any trade secret or confidential commercial documents submitted by the company to FDA until the advisory committee is lawfully constituted.

The lawsuit was filed jointly by Lorillard and R.J. Reynolds Tobacco Company in the United States District Court for the District of Columbia. The advisory committee is expected to submit a non- binding recommendation on the use of menthol in cigarettes to the FDA by March 23, 2011.

See the full content of this document

Extract


Lorillard Suit Alleges Financial Conflict and Bias Among Fda Advisory Committee Members

The suit alleges that the Tobacco Products Scientific Advisory Committee as currently constituted fails to meet requirements of the Federal Advisory Committee Act to be fairly balanced and not to be inappr...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company